Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir

Por Prichard, Mark N.
Publicado em 2009

The Search for New Therapies for Human Cytomegalovirus Infections

Por Prichard, Mark N., Kern, Earl R.
Publicado em 2010

Antiviral Activity of 4′-thioIDU and Thymidine Analogs against Orthopoxviruses

Por Prichard, Mark N., Kern, Earl R.
Publicado em 2010

Progress in the Development of New Therapies for Herpesvirus Infections

Por Price, Nathan B., Prichard, Mark N.
Publicado em 2011

Orthopoxvirus targets for the development of new antiviral agents

Por Prichard, Mark N., Kern, Earl R.
Publicado em 2012

Orthopoxvirus Targets for the Development of Antiviral Therapies

Por Prichard, Mark N., Kern, Earl R.
Publicado no Curr Drug Targets Infect Disord (2005)

The Development of New Therapies for Human Herpesvirus 6

Por Prichard, Mark N., Whitley, Richard J.
Publicado no Curr Opin Virol (2014)

Comparison of Three Dimensional Synergistic Analyses of Percentage Versus Logarithmic Data in Antiviral Studies

Por Smee, Donald F., Prichard, Mark N.
Publicado no Antiviral Res (2017)

Human cytomegalovirus UL97 kinase alters the accumulation of CDK1

Por Gill, Rachel B., James, Scott H., Prichard, Mark N.
Publicado em 2012

Requirement for Uracil-DNA Glycosylase during the Transition to Late-Phase Cytomegalovirus DNA Replication

Por Courcelle, Charmain Tan, Courcelle, Justin, Prichard, Mark N., Mocarski, Edward S.
Publicado em 2001

(Z)- and (E)-2-(1,2-Dihydroxyethyl)methylenecyclopropane Analogues of 2’-Deoxyadenosine and 2’-Deoxyguanosine. Synthesis of All Stereoisomers, Absolute Configuration and Antiviral...

Por Zhou, Shaoman, Drach, John C., Prichard, Mark N., Zemlicka, Jiri
Publicado em 2009

Reassessing the Organization of the UL42 – UL43 Region of the Human Cytomegalovirus Strain AD169 Genome

Por Mocarski, Edward S., Prichard, Mark N., Tan, Charmain S., Brown, Janice M.
Publicado no Virology (1997)

Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation

Por Wolf, Dana G., Courcelle, Charmain Tan, Prichard, Mark N., Mocarski, Edward S.
Publicado em 2001

Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections

Por Prichard, Mark N., Keith, Kathy A., Quenelle, Debra C., Kern, Earl R.
Publicado em 2006

Fluorinated methylenecyclopropane analogues of nucleosides. Synthesis and antiviral activity of (Z)- and (E)-9-{[(2-fluoromethyl-2-hydroxymethyl)-cyclopropylidene]methyl}adenine an...

Por Li, Chengwei, Prichard, Mark N., Korba, Brent E., Drach, John C, Zemlicka, Jiri
Publicado em 2007

Phosphonate Analogues of Cyclopropavir Phosphates and Their E-isomers. Synthesis and Antiviral Activity

Por Mhaske, Santosh B., Ksebati, Bashar, Prichard, Mark N., Drach, John C., Zemlicka, Jiri
Publicado em 2009

Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir

Por Li, Chengwei, Quenelle, Debra C., Prichard, Mark N., Drach, John C., Zemlicka, Jiri
Publicado em 2012

Human cytomegalovirus plasmid-based amplicon vector system for gene therapy

Por Mahmood, Kutubuddin, Prichard, Mark N, Duke, Gregory M, Kemble, George W, Spaete, Richard R
Publicado em 2005

Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir

Por Gill, Rachel B, Frederick, Samuel L, Hartline, Caroll B, Chou, Sunwen, Prichard, Mark N
Publicado em 2009

Virucidal Activity of Polysaccharide Extracts from Four Algal Species against Herpes Simplex Virus

Por Harden, Emma A., Falshaw, Ruth, Carnachan, Susan M., Kern, Earl R., Prichard, Mark N.
Publicado em 2009